Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

Part of paid clinical trials in Cincinnati, Ohio.

Sponsor
University of Cincinnati
Study ID
NCT06416007
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Cancer
  • Locally Advanced
  • Locally Advanced Carcinoma
  • Locally Advanced Solid Tumor
  • Metastatic Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Lattice therapy (LRT) — RADIATION
    5 Fractions LRT

Study Details

The purpose of this research study is to determine if lattice radiation therapy (LRT) will provide better treatment for bulky (large) tumors than current standard of care radiotherapy.

Key Dates

Start date
Aug 2, 2024
Status verified
Apr 2026
Primary completion
Jan 1, 2027
Completion
Jun 1, 2027

Study Design

Enrollment
37 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Lattice radiation therapy (LRT)
    Lattice radiation therapy (LRT) : 5 fractions

Primary Outcome Measure

Overall Response Rate [ Time Frame: 60 days post treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Cincinnati Medical CenterCincinnatiOhio45219
Andrew Frankart, MD

Find similar trials in Cincinnati, OH

By research site
University of Cincinnati Medical Center· Cincinnati, OH

Related Studies